If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Further Update on Agreement

8 Sep 2008 07:00

RNS Number : 8987C
Quadrise Fuels International PLC
08 September 2008
 



8 September 2008

Quadrise Fuels International plc

 

Quadrise Fuels International plc ("QFI"), the producer of emulsion fuel as a low cost substitute for heavy fuel oil for use in power generation plants and industrial diesel engines, today advises that subsequent to its announcement of 7 August 2008, it has now successfully completed the manufacture and shipment of the 20,000 tonne commercial batch of MSAR® (Multi-phase Superfine Atomised Residue) pursuant to the terms of its contracts with AB Mazeikiu Nafta and AB Lietuvos Elektrine.

In June 2008, the Company announced that it had entered into an agreement with AB Lietuvos Elektrine to undertake a major commercial demonstration at its Elektrenai plant using MSAR® emulsion fuel.

The Company, together with its technology partner Akzo Nobel, concluded the manufacture of the contracted tonnage of MSAR® on the Mazeikiu refinery site on 3 September 2008Operations at Elektrenai have progressed significantly over the past week, with two 150MWe boilers burning MSAR® fuel and reliably producing up to 300MWe of power into the Lithuanian grid, whilst complying with stringent EU emissions standards. Completion of the burn and the overall commercial demonstration is scheduled to occur during September. All work on the site, to date, has been completed with a 100% safety record.

Bill Howe, Chief Executive Officer at QFI, said: "We are extremely pleased with the success of this demonstration and see it as a clear validation of our technology. We are particularly pleased that we achieved our objectives with zero lost time incidents during the construction and manufacturing operations which is testament to the professionalism and commitment of our own and Akzo Nobel staff.

"In addition to Lithuaniawe have a number of other core business prospects that we are working on, the development of which will be greatly facilitated by the successful conclusion of the current commercial demonstration. These prospects cover both power plant re-fuelling and enhanced oil recovery using MSAR® generated steam. We are confident that a breakthrough in Lithuania will be the catalyst for the deployment of our technology elsewhere in the world."

The Company held an open day at the refinery site for potential customers on 27 August. Visitors attended from CanadaUSAMexicoFinlandSwedenBelgiumFrance and Poland

ends

For additional information, please contact:

Quadrise Fuels International +44 (0) 772 537 2841

Bill Howe

Smith & Williamson Corporate Finance Limited +44 (0) 20 7131 4000

Azhic Basirov / Siobhan Sergeant

Capital MS&L +44 (0) 20 7307 5330

Penny Freer

James Madsen

www.quadrisefuels.com/

Notes to Editors

Quadrise Fuels International plc ("QFI") produces an emulsion fuel as a low cost substitute for conventional heavy fuel oil ("HFO") for use in power generation plants and industrial diesel engines.

In manufacturing its fuels, QFI uses the least valuable elements of the oil barrel, thus providing a lower cost liquid fuel product which is also competitive with natural gas.

The emulsion fuel product, termed MSAR® (Multiphase Superfine Atomised Residue), has superior combustion characteristics to conventional heavy fuel oil, achieving complete carbon burn-out and producing lower NOx emissions.

Oil refiners applying the technology enjoy enhanced value realisation for their least valuable residues and the potential to avoid very heavy capital expenditure on heavy oil upgrading facilities. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURMGGGLLKFGRZM
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
29th Nov 20197:00 amRNSAGM Update
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.